In vitro exposure of DLBCL cell lines to pevonedistat resulted in changes in the expression of BCL‐2 family members suggesting a pro‐apoptotic micro‐environment, including the downregulation of BCL‐2/BCL‐XL and increased expression of BAK. The gene discussed is BAK1; the disease is diffuse large B-cell lymphoma.